Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Countrywide	Integra Resources	The Bank of Princeton	Nicox	Poxel
Symbol	OTCMKTS:CYWDF	OTCMKTS:IRRZF	NASDAQ:BPRN	OTCMKTS:NICXF	OTCMKTS:PXXLF
Price Information
Current Price	$5.42	$1.50	$30.21	$5.08	$8.00
52 Week Range	N/A	Buy	Buy	N/A	Buy
MarketRank™
Overall Score	0.4	1.1	1.9	0.5	0.6
Analysis Score	0.0	3.5	2.5	0.0	0.0
Community Score	1.9	2.0	2.5	1.9	2.3
Dividend Score	0.0	0.0	2.5	0.0	0.0
Ownership Score	0.0	0.0	0.8	0.0	0.0
Earnings & Valuation Score	0.0	0.0	1.3	0.6	0.6
Analyst Ratings
Consensus Recommendation	N/A	Buy	Buy	N/A	Buy
Consensus Price Target	N/A	$3.20	$33.33	N/A	N/A
% Upside from Price Target	N/A	113.33% upside	10.34% upside	N/A	N/A
Trade Information
Market Cap	$177.58 million	$179.34 million	$203.88 million	$170.03 million	$192.72 million
Beta	N/A	N/A	0.63	0.88	0.95
Average Volume	N/A	93,090	16,553	700	250
Sales & Book Value
Annual Revenue	N/A	N/A	$63.10 million	$9.25 million	$88.11 million
Price / Sales	N/A	N/A	3.24	18.38	2.19
Cashflow	N/A	N/A	N/A	N/A	$0.64 per share
Price / Cash	N/A	N/A	N/A	N/A	12.50
Book Value	N/A	N/A	N/A	$4.14 per share	N/A
Price / Book	N/A	N/A	∞	1.23	∞
Profitability
Net Income	N/A	$-16,320,000.00	N/A	$-21,190,000.00	$15.97 million
EPS	N/A	N/A	$1.54	($0.69)	N/A
Trailing P/E Ratio	0.00	N/A	15.90	N/A	0.00
Forward P/E Ratio	∞	∞	16.16	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	N/A	N/A
Return on Equity (ROE)	N/A	-93.61%	N/A	N/A	N/A
Return on Assets (ROA)	N/A	-30.90%	N/A	N/A	N/A
Dividend
Annual Payout	N/A	N/A	$0.48	N/A	N/A
Dividend Yield	N/A	N/A	1.59%	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	31.17%	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	1 Years	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A
Ownership Information
Institutional Ownership Percentage	N/A	N/A	36.48%	N/A	N/A
Insider Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Miscellaneous
Employees	7,000	20	177	34	51
Shares Outstanding	32.76 million	119.56 million	6.76 million	33.47 million	24.09 million
Next Earnings Date	N/A	N/A	7/22/2021 (Estimated)	N/A	N/A
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	Poxel (OTCMKTS:PXXLF) Stock Price Down 2% americanbankingnews.com - April 27 at 12:46 AM
	Poxel S.A. reports Q1 results seekingalpha.com - April 21 at 12:20 PM
	Poxel Reports Financial Results for Full Year 2020 and Provides Corporate Update finance.yahoo.com - March 24 at 2:57 PM
	Poxel Announces Completion of Arbitration with Merck Serono finance.yahoo.com - February 24 at 7:41 AM
	Poxel Reports Financial Update for Cash and Revenue for the Full Year 2020 and Provides Corporate Update finance.yahoo.com - February 12 at 2:25 AM
	Poxel Regains Imeglimin Rights From Metavant finance.yahoo.com - January 14 at 2:35 PM
	Poxel Announces Financial Calendar for 2021 finance.yahoo.com - January 5 at 4:45 AM
	Poxel SA Stock , PXXLF markets.businessinsider.com - December 25 at 10:34 PM
	Poxel Announces Participation at Upcoming Virtual Investor Conferences finance.yahoo.com - December 17 at 8:26 AM
	Poxel Announces Additional Positive Phase 2a Results, and Phase 2b Plan for PXL770, an Oral First-in-Class AMPK Activator, in NASH finance.yahoo.com - December 14 at 3:04 AM
	Poxel announces its partner Metavant not to advance Imeglimin into phase 3 programme pharmabiz.com - November 23 at 9:07 AM
	Ahead of possible Japanese approval, Metavant backs away from Poxel-partnered imeglimin fiercebiotech.com - November 20 at 9:38 AM
	Poxel Presents Phase 1b Clinical Results for PXL065 and New Preclinical Data for PXL770 at AASLD The Liver Meeting® 2020 finance.yahoo.com - November 16 at 1:06 PM
	Poxel Announces Upcoming Poster Presentations at AASLD The Liver Meeting® 2020 finance.yahoo.com - November 9 at 2:07 PM
	PXXLF After-Hours Quotes nasdaq.com - October 18 at 7:09 PM
	Poxel Secures EUR 6 Million in Non-Dilutive Financing Guaranteed by the French Government news.yahoo.com - October 15 at 1:21 PM
	Poxel Announces Participation at Upcoming Scientific and Investor Conferences finance.yahoo.com - September 21 at 2:05 PM
	Poxel Reports Financial Results for First Half 2020 and Provides a Corporate Update finance.yahoo.com - September 15 at 2:06 PM
	Poxel initiates DESTINY 1 phase 2 trial of pioglitazone to treat NASH pharmabiz.com - September 4 at 10:06 AM
	Poxel to Host Conference Call for First Half 2020 Financial Results on September 15, 2020 finance.yahoo.com - September 3 at 1:51 PM
	Poxel Initiates Phase 2 NASH Trial for PXL065 (DESTINY 1) in Biopsy-Proven Patients finance.yahoo.com - September 2 at 7:43 AM
	Poxel annonce le dépôt de la demande d'enregistrement de l'Imeglimine au Japon www.msn.com - July 30 at 8:55 AM
	Poxel : des fonds gérés par Andera Partners pointent autour de 14% du capital www.boursier.com - July 28 at 6:01 PM
	Poxel Provides Corporate Update and Reports Cash and Revenue for the Second Quarter and First Half 2020 finance.yahoo.com - July 21 at 1:40 PM
	Poxel Announces Participation in Upcoming Virtual Investor Conferences finance.yahoo.com - May 28 at 12:45 PM

Date	Company	Brokerage	Action
6/19/2020	Integra Resources	Stifel Nicolaus	Boost Price Target
5/3/2021	The Bank of Princeton	Boenning Scattergood	Upgrade
4/29/2021	The Bank of Princeton	Piper Sandler	Upgrade
4/26/2021	The Bank of Princeton	B. Riley	Boost Price Target
4/23/2019	The Bank of Princeton	Sandler O'Neill	Downgrade
12/16/2019	Nicox	Cantor Fitzgerald	Initiated Coverage
1/31/2019	Nicox	HC Wainwright	Reiterated Rating
6/23/2020	Poxel	JMP Securities	Initiated Coverage

(Data available from 5/6/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources